Elevance Health Inc (ELV)

Currency in USD
290.19
-6.41(-2.16%)
Real-time Data·
ELV Scorecard
Full Analysis
Management has been aggressively buying back shares
ELV is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
290.00295.68
52 wk Range
274.40567.26
Key Statistics
Prev. Close
296.6
Open
290.9
Day's Range
290-295.68
52 wk Range
274.4-567.26
Volume
792.87K
Average Volume (3m)
2.05M
1-Year Change
-40.97%
Book Value / Share
193.52
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ELV Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
392.28
Upside
+35.18%
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield

Elevance Health Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Buy
Moving Averages
Sell

Elevance Health Inc Company Profile

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. The company offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. It also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, the company provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. It provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.

Elevance Health Inc SWOT Analysis


Resilient Amid Headwinds
Elevance Health navigates Medicaid challenges while maintaining strong market position and growth potential in specialty sales and other segments
Strategic Expansion
Delve into Elevance's recent acquisitions in specialty pharmacy, positioning the company for significant growth and vertical integration
Financial Outlook
Analysts project EPS of $37.31 for the current fiscal year, with an average price target of $599, indicating confidence in future performance
Industry Dynamics
Explore how Elevance adapts to healthcare trends, including Medicaid redetermination and Medicare cost management, shaping its competitive edge
Read full SWOT analysis

Elevance Health Inc Earnings Call Summary for Q2/2025

  • Q2 adjusted EPS of $8.84 missed forecast, revenue up 14% to $49.4B; stock dropped 9.03% pre-market to $331
  • Full-year adjusted EPS guidance lowered to ~$30; company focuses on AI and pharmacy services investments
  • Strong revenue growth driven by CarillonRx platform; challenges in ACA market and Medicaid enrollment persist
  • CEO emphasizes strategy of 'whole health solutions'; analysts question elevated medical cost trends and Medicaid challenges
  • Stock undervalued per InvestingPro; 15-year dividend streak, 2% yield; risks include ACA market deterioration, policy changes
Last Updated: 17/07/2025, 14:44
Read Full Transcript

Compare ELV to Peers and Sector

Metrics to compare
ELV
Peers
Sector
Relationship
P/E Ratio
12.5x9.3x−0.5x
PEG Ratio
−0.700.060.00
Price/Book
1.5x1.8x2.6x
Price / LTM Sales
0.4x0.8x3.2x
Upside (Analyst Target)
24.7%36.2%41.9%
Fair Value Upside
Unlock4.8%4.3%Unlock

Analyst Ratings

16 Buy
6 Hold
0 Sell
Ratings:
22 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 392.28
(+35.18% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 23.47%
Dividend Yield
2.31%
Industry Median 2.12%
Annualised payout
6.84
Paid quarterly
5-Years Growth
+13.80%
Growth Streak

Earnings

Latest Release
Jul 17, 2025
EPS / Forecast
8.84 / 9.07
Revenue / Forecast
49.40B / 48.14B
EPS Revisions
Last 90 days

ELV Income Statement

People Also Watch

28.53
CNC
-3.03%
224.30
LULU
+0.12%
289.11
UNH
-1.16%
302.04
CI
-0.76%
425.29
LMT
+1.41%

FAQ

What Stock Exchange Does Elevance Health Trade On?

Elevance Health is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for Elevance Health?

The stock symbol for Elevance Health is "ELV."

What Is the Elevance Health Market Cap?

As of today, Elevance Health market cap is 66.25B.

What Is Elevance Health's Earnings Per Share (TTM)?

The Elevance Health EPS (TTM) is 23.47.

When Is the Next Elevance Health Earnings Date?

Elevance Health will release its next earnings report on 14 Oct 2025.

From a Technical Analysis Perspective, Is ELV a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Elevance Health Stock Split?

Elevance Health has split 1 times.

How Many Employees Does Elevance Health Have?

Elevance Health has 104200 employees.

What is the current trading status of Elevance Health (ELV)?

As of 24 Jul 2025, Elevance Health (ELV) is trading at a price of 290.19, with a previous close of 296.60. The stock has fluctuated within a day range of 290.00 to 295.68, while its 52-week range spans from 274.40 to 567.26.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.